Inventor
ICHIM THOMAS
US44 patents
⚠️ This page may combine multiple inventors who share the name “ICHIM THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SPINALCYTE LLC
9 patentsUS11034934B2Jun 15, 2021
Methods of enhancing fibroblast therapeutic activity
SPINALCYTE LLC7 citations80
US12576112B2Mar 17, 2026
Inhibition of TNF-alpha by fibroblasts and fibroblast exosomes
SPINALCYTE LLC0 citations61
US12544408B2Feb 10, 2026
Prevention and treatment of kidney failure by administration of fibroblasts and products thereof
SPINALCYTE LLC0 citations61
US12508287B2Dec 30, 2025
Treatment of cerebral palsy using fibroblasts
SPINALCYTE LLC0 citations61
US12404494B2Sep 2, 2025
Prevention of recurrent miscarriages through administration of fibroblasts and fibroblast-educated paternal cells
SPINALCYTE LLC0 citations61
US12233094B2Feb 25, 2025
Interaction of fibroblasts and immune cells for activation and uses thereof
SPINALCYTE LLC0 citations61
US12133870B2Nov 5, 2024
Treatment of opioid addiction using fibroblasts and products thereof
SPINALCYTE LLC1 citations61
US12090174B2Sep 17, 2024
Fibroblast therapy for treatment of Duchenne muscular dystrophy
SPINALCYTE LLC1 citations61
US12310991B2May 27, 2025
Stimulation of angiogenesis by fibroblast derived exosomes
SPINALCYTE LLC1 citations60
REGEN BIOPHARMA INC
6 patentsUS11090332B2Aug 17, 2021
Antigen specific mRNA cellular cancer vaccines
REGEN BIOPHARMA INC2 citations70
US11141471B2Oct 12, 2021
Universal donor checkpoint inhibitor silenced/gene edited cord blood killer cells
REGEN BIOPHARMA INC3 citations65
US11712474B2Aug 1, 2023
Reduction of post-surgery cancer metastasis by combination of cannabidiol and NR2F6 inhibition
REGEN BIOPHARMA INC0 citations59
US11655474B2May 23, 2023
Suppression of pathological angiogenesis by inhibition of NR2F6
REGEN BIOPHARMA INC0 citations59
US11241427B2Feb 8, 2022
Small molecule modulators of NR2F6 activity
REGEN BIOPHARMA INC1 citations59
US11053503B2Jul 6, 2021
Methods and means of generating IL-17 associated antitumor effector cells by inhibition of NR2F6 inhibition
REGEN BIOPHARMA INC1 citations59
CREATIVE MEDICAL TECH INC
5 patentsUS12391925B2Aug 19, 2025
Prevention and/or treatment of type 1 diabetes by augmentation of myeloid suppressor cell activity
CREATIVE MEDICAL TECH INC0 citations61
US12385011B2Aug 12, 2025
Treatment of heart failure and/or post infarct pathological remodeling by ex vivo reprogrammed immune cells
CREATIVE MEDICAL TECH INC0 citations61
US11795433B2Oct 24, 2023
Generation of autologous immune modulatory cells for treatment of neurological conditions
CREATIVE MEDICAL TECH INC0 citations61
US10842815B2Nov 24, 2020
Perispinal perfusion by administration of T regulatory cells alone or in combination with angiogenic cell therapies
CREATIVE MEDICAL TECH INC1 citations61
US10792310B2Oct 6, 2020
Methods for treatment of premature ovarian failure and ovarian aging using regenerative cells
CREATIVE MEDICAL TECH INC0 citations51
FIGENE LLC
4 patentsUS11975030B2May 7, 2024
Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereof
FIGENE LLC1 citations60
US11959102B2Apr 16, 2024
Augmentation of fibroblast regenerative activity
FIGENE LLC1 citations60
US11878037B2Jan 23, 2024
Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis
FIGENE LLC1 citations60
US11732239B2Aug 22, 2023
Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof
FIGENE LLC0 citations60
AETHLON MEDICAL INC
2 patentsVIERA BIOSCIENCE INC
2 patentsFIBROBIOLOGICS INC
2 patentsTHERAPEUTIC SOLUTIONS INT INC
2 patentsUS11951146B2Apr 9, 2024
Stimulation of NK cell activity by using a combination of broccoli, Nigella Sativa, Green Tea, and pterostilbene alone and together with metformin
THERAPEUTIC SOLUTIONS INT INC0 citations52
US9682047B2Jun 20, 2017
Augmentation of oncology immunotherapies by pterostilbene containing compositions
THERAPEUTIC SOLUTIONS INT INC0 citations45
ZANDER THERAPEUTICS INC
2 patentsNOBILIS THERAPEUTICS INC
2 patentsNOBLIS THERAPEUTICS INC
2 patentsUS10376539B2Aug 13, 2019
Augmentation of antiinflammatory, immunomodulatory, and regenerative processes in amyotrophic lateral sclerosis using xenon and noble gas combinations
NOBLIS THERAPEUTICS INC0 citations43
US10485825B2Nov 26, 2019
Prevention of pregnancy complications by noble gas administration
NOBLIS THERAPEUTICS INC0 citations42